UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, DC 20549




FORM 10-Q




QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the Quarterly Period Ended September 30, 2017

2023

or


TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the Transition Period From ________transition period from  to _________


Commission File Number 000-50009


PACIFIC HEALTH CARE ORGANIZATION, INC.

  (Exact

(Exact name of registrant as specified in its charter)

  

Utah

87-0285238

(State or other jurisdiction of incorporation or organization)

(I.R.S. Employer I.D.Identification No.)

  
1201 Dove Street, Suite 300

19800 MacArthur Boulevard, Suites 306 & 307

 
Newport Beach,

Irvine, California

92660

92612

(Address of principal executive offices)

(Zip Code)


(949) 721-8272

(Registrant’s telephone number, including area code)


Securities registered pursuant to Section 12(b) of the Act:

Title of each class

Trading symbol

Name of each exchange on which registered

None

N/A

N/A

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for any shorter period that the registrant was required to file such reports) and (2) has been subject to such filing requirements for the past 90 days. Yes No

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files.) Yes No

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an emerging growth company. See definitions of “large accelerated filer,” “accelerated filer,,smaller reporting company” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

Large accelerated filer

Accelerated filer

Non-accelerated filer (Do not check if a smaller reporting company)

Smaller reporting company

Emerging growth company

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.


Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act.) Yes No


As of November 10, 2017,14, 2023, the registrant had 800,00012,800,000 shares of common stock, par value $0.001, issued and outstanding.

 



PACIFIC HEALTH CARE ORGANIZATION, INC.

FORM 10-Q

TABLE OF CONTENTS

 

Page

PART I — FINANCIAL INFORMATION

 
  

3
   
 3

(Unaudited) Statements of Operations for the Three and Nine Months Ended September 30, 20172023 and 20162022

4
   
 5

(Unaudited) Statements of Cash Flows for the Nine Months Ended September 30, 20172023 and 20162022

56
   
 

67
  

810
  

1924
  

1924
  

PART II — OTHER INFORMATION

 
  

2025
  

2025
  

2126

 

PART I. FINANCIAL INFORMATION

Item 1. Condensed Consolidated Financial InformationStatements

Pacific Health Care Organization, Inc.

Condensed Consolidated Balance Sheets

(Unaudited)

(Unaudited)

 

September 30,

  

December 31,

 
 

2023

  

2022

 
ASSETS              
 
September 30,
2017
  
December 31,
2016
 
Current Assets              
Cash $5,613,412  $5,005,617  $2,359,882  $2,036,432 
Accounts receivable, net of allowance of $60,150 and $64,150  985,787   849,648 
Deferred tax asset  11,661   11,661 

Investments

  7,769,403   8,748,435 

Accounts receivable, net of allowance of $9,302 and $7,807

  832,826   934,990 

Receivable – other

  -   3,000 

Prepaid income tax

  82,000   - 
Prepaid expenses  142,950   136,862   189,445   175,355 
Total current assets  6,753,810   6,003,788   11,233,556   11,898,212 
                
Property and Equipment, net                
Computer equipment  363,402   349,955   259,334   256,500 
Furniture and fixtures  212,823   206,785   21,620   20,328 
Office equipment  9,556   15,595 
Total property and equipment  585,781   572,335   280,954   276,828 
Less: accumulated depreciation  (405,154)  (346,295)

Less: accumulated depreciation and amortization

  (207,075

)

  (179,423

)

Net property and equipment  180,627   226,040   73,879   97,405 

Operating lease right-of-use assets, net

  -   50,137 

Other assets

  7,110   6,602 

Total Assets

 $11,314,545  $12,052,356 
                
Other Assets  26,788   26,788 
Total assets $6,961,225  $6,256,616 
        
LIABILITIES AND STOCKHOLDERS’ EQUITY        

LIABILITIES AND STOCKHOLDERS EQUITY

        
         
Current Liabilities                
Accounts payable $62,924  $101,294  $121,925  $263,022 
Accrued expenses  278,903   253,367   314,687   332,551 
Deferred rent expense  39,358   17,485 
Income tax payable  21,115   31,226   193,258   3,132 
Dividend payable  56,923   56,923 

Dividends payable

  109,333   37,000 

Operating lease liabilities, current portion

  -   39,620 
Unearned revenue  37,763   38,748   37,315   33,544 
Total current liabilities  496,986   499,043   776,518   708,869 
                
Total liabilities  496,986   499,043 

Long Term Liabilities

        

Operating lease liabilities, long term portion

  -   10,517 

Deferred tax liabilities

  15,679   15,679 

Total Liabilities

 $792,197  $735,065 
                
Commitments and Contingencies  -   -   -   - 
                
Stockholders’ Equity         
Preferred stock, 5,000,000 shares authorized at $0.001 par value of
which 10,000 shares designated as Series A preferred and 1,000 shares
issued and outstanding at September 30, 2017 and December 31, 2016
  1   1 
Common stock, $0.001 par value: 50,000,000 shares authorized; 800,000 shares issued and
outstanding at September 30, 2017 and December 31, 2016
  800   800 

Stockholders Equity

        

Convertible preferred stock, $0.001 par value, 5,000,000 shares authorized of which 40,000 shares designated as Series A preferred and 16,000 shares issued and outstanding

  16   16 

Common stock, $0.001 par value, 800,000,000 shares authorized, 12,800,000 shares issued and outstanding

  12,800   12,800 
Additional paid-in capital  428,072   428,072   416,057   416,057 
Retained earnings  6,035,366   5,328,700   10,093,475   10,888,418 
Total stockholders’ equity  6,464,239   5,757,573 
Total liabilities and stockholders’ equity $6,961,225  $6,256,616 

Total stockholders equity

  10,522,348   11,317,291 

Total Liabilities and Stockholders Equity

 $11,314,545  $12,052,356 

The accompanying notes are an integral part of these unaudited condensed consolidated financial statementsstatements.


Pacific Health Care Organization, Inc.

Condensed Consolidated Statements of Operations

(Unaudited)

(Unaudited)


 
For three months ended
September 30,
  
For nine months ended
September 30,
  

For three months ended

September 30,

  

For nine months ended

September 30,

 
 2017  2016  2017  2016  

2023

  

2022

  

2023

  

2022

 
            
Revenues            
HCO fees $377,923  $276,951  $1,041,328  $965,768 
MPN fees  142,257   146,836   427,228   436,893 
UR fees  277,886   221,176   788,229   596,205 
MBR fees  147,094   187,829   481,352   517,893 
NCM fees  582,544   499,118   1,824,121   1,176,447 

Revenues:

                

HCO

 $373,280  $354,913  $945,759  $985,192 

MPN

  132,403   128,297   392,789   422,227 

Medical bill review

  90,988   99,418   266,030   333,310 

Medical case management

  292,195   384,657   922,273   1,218,077 

Utilization review

  451,167   443,049   1,360,998   1,220,941 
Other  73,203   111,686   255,542   309,260   36,006   43,663   99,727   102,084 
Total revenues  1,600,907   1,443,596   4,817,800   4,002,466   1,376,039   1,453,997   3,987,576   4,281,831 
                                
Expenses                
Depreciation and amortization  19,462   20,925   58,859   63,247 

Expenses:

                

Depreciation

  8,936   9,661   27,652   23,153 
Bad debt provision  15,750   4,500   30,500   13,500   1,265   (5,520

)

  2,429   (737

)

Consulting fees  90,079   75,228   246,073   265,296   56,418   56,148   173,235   166,309 
Salaries and wages  547,963   574,100   1,734,321   1,717,148   638,288   699,026   1,927,044   2,018,638 
Professional fees  109,064   82,105   308,295   224,368   89,677   76,065   263,880   222,703 
Insurance  79,489   81,452   257,495   243,307   81,003   79,974   229,599   238,851 
Outsource service fees  146,287   113,017   404,538   288,225��  180,579   156,677   529,861   433,275 
Data maintenance  12,160   30,160   71,261   113,175   4,524   2,898   69,278   59,400 
General and administrative  162,164   157,894   495,474   475,230   168,344   112,135   390,019   418,079 
Total expenses  1,182,418   1,139,381   3,606,816   3,403,496   1,229,034   1,187,064   3,612,997   3,579,671 
                                
Income from operations  418,489   304,215   1,210,984   598,970   147,005   266,933   374,579   702,160 
                                

Other income (expense)

                

Interest income

  102,017   -   301,991   - 

Total other income (expense)

  102,017   -   301,991   - 
                
Income before taxes  418,489   304,215   1,210,984   598,970   249,022   266,933   676,570   702,160 
Income tax provision  174,560   126,882   504,318   249,529   (69,901

)

  (74,928

)

  (189,913

)

  (197,096

)

                                
Net income $243,929  $177,333  $706,666  $349,441  $179,121  $192,005  $486,657  $505,064 
                                
Basic and fully diluted earnings per share:                

Basic earnings per share:

                
Earnings per share amount $.30  $.22  $.88  $.44  $0.01  $0.02  $0.04  $0.04 
Weighted average common shares outstanding  800,000   800,000   800,000   800,000 

Basic common shares outstanding

  12,800,000   12,800,000   12,800,000   12,800,000 
                

Fully diluted earnings per share:

                

Earnings per share amount

 $0.01  $0.01  $0.04  $0.04 

Fully diluted common shares outstanding

  12,816,000   12,816,000   12,816,000   12,816,000 

The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.


Pacific Health Care Organization, Inc.

Condensed Consolidated Statements of Cash FlowsStockholders' Equity

(Unaudited)

(Unaudited)

  
Nine Months Ended
September 30,
 
  2017  2016 
Cash flows from operating activities:      
Net income $706,666  $349,441 
Adjustments to reconcile net income to net cash from operations:        
Depreciation and amortization  58,859   63,247 
Changes in operating assets and liabilities:        
   (Decrease) increase in bad debt provision  (4,000)  12,260 
   (Increase) decrease in accounts receivable  (132,139)  303,051 
   (Increase) in prepaid expenses  (6,088)  (58,530)
   Decrease in prepaid income tax  -   238,805 
   (Decrease) in accounts payable  (38,370)  (22,914)
   Increase in deferred rent expense  21,873   10,131 
   Increase in accrued expenses  25,536   111,343 
   (Decrease) increase in income tax payable  (10,111)  10,424 
   (Decrease) in unearned revenue  (985)  (4,692)
   Decrease in deferred compensation  -   37,124 
      Net cash provided from operating activities  621,241   1,049,690 
         
Cash flows from investing activities:         
Purchase of computer equipment, furniture and office equipment  (13,446)  (33,556)
Net cash used in investing activities  (13,446)  (33,556)
         
Cash flows from financing activities:        
Issuance of cash dividend  -   (2,063)
Net cash used in financing activities  -   (2,063)
         
 Increase in cash  607,795   1,014,071 
Cash at beginning of period  5,005,617   3,834,924 
Cash at end of period $5,613,412  $4,848,995 
         
Supplemental cash flow information        
Cash paid for:        
Interest $-  $- 
Income taxes paid $514,429  $300 
  

Convertible

Preferred Stock

  

Common Stock

  

Additional

Paid-in

  

Retained

  

Total

Stockholders’

 
  

Shares

  

Amount

  

Shares

  

Amount

  

Capital

  

Earnings

  

Equity

 

Balances at December 31, 2021

  16,000  $16   12,800,000  $12,800  $416,057  $10,395,532  $10,824,405 

Net Income

  -   -   -   -   -   188,535   188,535 

Balances at March 31, 2022

  16,000  $16   12,800,000  $12,800  $416,057  $10,584,067  $11,012,940 

Net Income

  -   -   -   -   -   124,524   124,524 

Balances at June 30, 2022

  16,000  $16   12,800,000  $12,800  $416,057  $10,708,591  $11,137,464 

Net Income

  -   -   -   -   -   192,005   192,005 

Balances at September 30, 2022

  16,000  $16   12,800,000  $12,800  $416,057  $10,900,596  $11,329,469 
                             

Balances at December 31, 2022

  16,000  $16   12,800,000  $12,800  $416,057  $10,888,418  $11,317,291 

Net Income

  -   -   -   -   -   131,109   131,109 

Balances at March 31, 2023

  16,000  $16   12,800,000  $12,800  $416,057  $11,019,527  $11,448,400 

Net Income

  -   -   -   -   -   176,427   176,427 

Common stock cash dividends paid

  -   -   -   -   -   (1,280,000

)

  (1,280,000

)

Preferred stock cash dividends paid

  -   -   -   -   -   (1,600

)

  (1,600

)

Balances at June 30, 2023

  16,000  $16   12,800,000  $12,800  $416,057  $9,914,354  $10,343,227 

Net Income

  -   -   -   -   -   179,121   179,121 

Balances at September 30, 2023

  16,000  $16   12,800,000  $12,800  $416,057  $10,093,475  $10,522,348 



The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.



Pacific Health Care Organization, Inc.

Condensed Consolidated Statements of Cash Flows

(Unaudited)

  

Nine Months Ended

September 30,

 
  

2023

  

2022

 

Cash flows from operating activities:

        

Net income

 $486,657  $505,064 

Adjustments to reconcile net income to net cash provided by operating activities:

        

Depreciation

  27,652   23,153 

Bad debt provision

  2,429   (737

)

Noncash interest on investments

  (126,422

)

  - 
         

Changes in operating assets and liabilities:

        

Decrease in accounts receivable

  99,735   64,657 

Decrease in deferred rent assets

  -   10,055 

Increase in prepaid expenses

  (14,090

)

  (60,359

)

Decrease in income taxes receivable

  -   19,779 

Decrease in receivable - other

  3,000   - 

Increase in prepaid income tax

  (82,000

)

  - 

(Increase) decrease in other assets

  (508

)

  20,186 

(Decrease) increase in accounts payable

  (141,097

)

  44,438 

Decrease in accrued expenses

  (17,864

)

  (68,221

)

Increase in unearned revenue

  3,771   6,979 

Increase in income tax payable

  190,126   7,316 

Net cash provided by operating activities

  431,389   572,310 
         

Cash flows from investing activities:

        

Proceeds from investments

  8,748,435   - 

Purchase of investments

  (7,642,981

)

  - 

Purchase of furniture and office equipment

  (4,126

)

  (17,619

)

Net cash provided by (used in) investing activities

  1,101,328   (17,619

)

         

Cash flows from financing activities:

        

Issuance of cash dividend

  (1,209,267

)

  - 

Net cash used in financing activities

  (1,209,267

)

  - 

Increase in cash

  323,450   554,691 
         

Cash at beginning of period

 $2,036,432  $10,085,372 

Cash at end of period

 $2,359,882  $10,640,063 
         

Supplemental cash flow information

        

Cash paid for:

        

Interest

 $-  $- 

Income taxes

 $82,000  $170,000 
         

Non-cash investing and financing activities:

        

Dividends payable

 $72,333  $- 

The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.

Pacific Health Care Organization, Inc.

Notes to Condensed Consolidated Financial Statements

For the Nine Months Ended September 30, 20172023

(Unaudited)

(Unaudited)


NOTE 1 - BASIS OF FINANCIAL STATEMENT PRESENTATION


The accompanying unaudited condensed consolidated financial statements have been prepared by the Company pursuant to the rules and regulations of the Securities and Exchange Commission (the “Commission”) and in accordance with accounting principles generally accepted in the United States (“GAAP”). Certain information and footnote disclosures normally included in consolidated financial statements have been condensed or omitted in accordance with GAAP rules and regulations. The information furnished in these interimunaudited condensed consolidated financial statements includes normal recurring adjustments and reflects all adjustments, which, in the opinion of management, are necessary for a fair presentation of such financial statements. The preparation of condensed consolidated financial statements in accordance with GAAP requires management to make estimates and assumptions that affect both the recorded values of assets and liabilities at the date of the condensed consolidated financial statements and the revenues recognized and expenses incurred during the reporting period. These estimates and assumptions affect the Company’s recognition of deferred expenses, bad debts, income taxes, the carrying value of its long-lived assets and its provision for certain contingencies. The reasonableness of these estimates and assumptions is evaluated continually based on a combination of historical information and other information that comes to the Company’s attention that may vary its outlook for the future. While management believes the disclosures and information presented are adequate to make the information not misleading, it is suggested thatthe Company recommends these interimunaudited condensed consolidated financial statements be read in conjunction with the Company’sits audited financial statements and notes thereto included in its annual report on Form 10-K for the year ended December 31, 2016.2022. Operating results for the nine monthsnine-month period ended September 30, 2017,2023, are not necessarily indicative of the results to be expected for the year ending December 31, 2017.


2023.

Principles of Consolidation — The accompanying unaudited condensed consolidated financial statements include the accounts of the Company and its wholly-owned subsidiaries. Intercompany transactions and balances have been eliminated in consolidation.


Basis of AccountingThe Company uses the accrual method of accounting.


accounting in accordance with accounting principles generally accepted in the United States for the periods ended September 30, 2023 and 2022.

Revenue RecognitionIn general, theThe Company recognizes revenue in accordance with ASU 2014-09, “Revenue from Contracts with Customers (Topic 606).” The core principle underlying Topic 606 is that the Company will recognize revenue to represent the transfer of goods and services to customers in an amount that reflects the consideration to which the Company expects to be entitled in such exchange. This will require the Company to identify contractual performance obligations and determine whether revenue should be recognized at a point in time or over time, based on when control of goods and services transfers to a customer.

ASC 606 requires the use of a five-step model to recognize revenue from customer contracts. The five-step model requires that the Company (i) persuasive evidence of an arrangement exists,identify the contract with the customer, (ii) delivery has occurred or services have been rendered,identify the performance obligations in the contract, (iii) determine the feetransaction price, including variable consideration to the extent that it is fixed or determinableprobable that a significant future reversal will not occur, (iv) allocate the transaction price to the respective performance obligations in the contract, and (iv) collectability is reasonably assured.(v) recognize revenue when (or as) the Company satisfies the performance obligation. Revenues are generated as services are provided to the customer based on the sales price agreed and collected. The Company recognizes revenue as the time is worked or as units of production are completed, which is when the revenue is earned and realized. Labor costs are recognized as the costs are incurred.

The Company derives its revenue from the sale of Managed Care Services, Review Servicesservices offered through its HCOs, MPNs, medical bill review, medical case management, employee advocate, utilization review, workers’ compensation carve-outs, and Case Management Services.Medicare set-aside. These services are billed individually as separate components to our customers.


These Services from which we generate fees include monthly and/or annual HCO and/or MPN administration, fees, claim and network fees, legal support fees, Medicare set aside fees, lien service fees,access, medical bill review, medical case management, employee advocate, utilization review, workers’ compensation carve-outs, flat rate fees or hourly fees depending onand Medicare set-aside.

Pacific Health Care Organization, Inc.

Notes to Condensed Consolidated Financial Statements

For the agreement with the client.  Such revenue is recognized at the end of each monthNine Months Ended September 30, 2023

(Unaudited)

The Company enters arrangements for which services are performed.


Management reviews each agreement in accordance with the provisions of revenue recognition topic ASC 605. Arrangements entered into in such agreements consist of bundled managed care, standalone services, or add-on ancillary services which includesinclude various units of accounting such as network solutions and patient management, includingand managed care. Such elements are considered separate units of accounting due to each element having value to the customer on a stand-alone basis and are billed separately. The selling price for each unit of accounting is determined using the contract price. When the Company’s customers purchase several productsservices, the pricing of the productsservice sold is generally the same as if the productsservices were sold on an individual basis. Revenue is recognized as the work is performed in accordance with the Company’s customer contracts. Based upon the nature of the Company’s products,services, bundled managed care elements are generally delivered in the same accounting period. The Company recognizes revenue for patient management services ratably over the life of the customer contract. Based upon prior experience in managed care, the Company estimates the deferral amount from when the customer’s claim is received to when the customer contract expires. Advance payments from subscribers and billings made in advance are recorded on the balance sheet as deferred revenue.


Accounts ReceivablesReceivable and Bad Debt Allowance – In the normal course of business the Company extends credit to its customers on a short-term basis. Although the credit risk associated with these customers is minimal, the Company routinely reviews its accounts receivable balances and makes provisions for doubtful accounts. The Company ages its receivables by date of invoice.invoice date. Management reviews bad debt reserves quarterly and reserves specific accounts as warranted or sets up a general reserve based on amounts over 90 days past due. When an account is deemed uncollectible, the Company charges off the receivable against the bad debt reserve. A considerable amount of judgment is required in assessing the realization of these receivables including the current creditworthiness of each customer and related aging of the past-due balances, including any billing disputes. In order toTo assess the collectability of these receivables, the Company performs ongoing credit evaluations of its customers’ financial condition. Through these evaluations, the Company may become aware of a situationsituations where a customer may not be able to meet its financial obligations due to deterioration of its financial viability, credit rating or bankruptcy. The allowance for doubtful accounts is based on the best information available to the Company and is reevaluated and adjusted as additional information is received. We evaluateThe Company evaluates the allowance based on historical write-off experience, the size of the individual customer balances, past-due amounts, and the overall national economy. At September 30, 20172023 and December 31, 2016,2022, bad debt reserves of $60,150$9,302 and $64,150,$7,807, respectively, waswere maintained in a general reserve for certain balances over 90 days past due and for accounts that are potentially uncollectible.


uncollectible accounts.

The percentages of the amounts due from major customers to total accounts receivable as of September 30, 20172023 and September 30, 2016,December 31, 2022, are as follows:

  9/30/2017  9/30/2016 
Customer A  9%  18%
Customer B  3%  10%
Customer C  -%  12%
Customer D  1%  10%
Customer E  14%  11%
Customer F  32%  -%

  

9/30/2023

  

12/31/2022

 

Customer A

  34

%

  18

%

Customer B

  12

%

  7

%

Customer C

  8

%

  24

%

Significant Customers - We provideThe Company provides services to insurers, third party administrators, self-administered employers, municipalities, and other industries. We areThe Company is able to provide ourits full range of services to virtually any size employer in the state of California. We are alsoOutside the state of California, the Company is able to provide UR, MBRutilization review, medical bill review and NCM services outside the state of California. 


medical case management services.

During the periodperiods ended September 30, 20172023 and 2016, we2022, the Company had three and four customers, respectively, that individually accounted for more than 10% of ourits total sales. The following table sets forth details regarding the percentagepercentages of total sales attributable to those customers during those periods:

  

9/30/2023

  

9/30/2022

 

Customer A

  24

%

  28

%

Customer B

  10

%

  10

%

Customer C

  10

%

  9

%

Leases - The Company follows the guidance of ASC 842, Leases, which requires an entity to recognize a right-of-use asset and a lease liability for virtually all leases. The Company elected to exclude from its balance sheet the recognition of leases having a term of 12 months or less. Lease expense is recognized on a straight-line basis over the lease term. See Note 2 for further information regarding the Company’s leases.

Pacific Health Care Organization, Inc.

Notes to Condensed Consolidated Financial Statements

For the Nine Months Ended September 30, 2023

(Unaudited)

NOTE 2 - OPERATING LEASES

On April 1, 2022, the Company moved office locations from 1201 Dove Street, Suite 300 in Newport Beach, California to 19800 MacArthur Boulevard, Suites 306 & 307, in Irvine, California. This lease was to expire as of March 31, 2023, but was renewed on December 10, 2022, for an additional 12-months, with a new expiration of March 31, 2024. The Company elected to exclude from its balance sheet the recognition of leases having a term of 12 months or less.

Lease expenses were $10,714 and $9,903 during the three-month periods ended September 30, 2023 and 2022, respectively; and $31,407 and $19,806 during the nine-month periods ended September 30, 2023 and 2022, respectively.

NOTE 3 SHAREHOLDERS EQUITY

During the quarter ended June 30, 2023, our significant customersboard of directors declared a special one-time cash dividend of $0.10 per share on each share of Company common stock outstanding at the record date of June 5, 2023. Pursuant to the rights provided in the past two years:Designation of Rights, Privileges and Preferences of Series A Preferred Stock dated December 27, 2019, holders of the Company’s Series A Preferred Stock participated in the dividend payment based on the number of shares of Series A Preferred Stock held on the record date. On the record date, June 5, 2023, we had 12,800,000 shares of common stock and 16,000 shares of Series A Preferred stock issued and outstanding.

As of September 30, 2023, we issued $1,281,600 in dividends with $72,333 of that amount remaining payable. This payable has been accrued and included in the dividends payable on the balance sheet.


  9/30/2017  9/30/2016 
Customer A  20%  0%
Customer B  13%  15%
Customer C  11%  10%
Customer D  7%  13%
Customer E  7%  10%


NOTE 24 - SUBSEQUENT EVENTS

In accordance with ASC 855-10 Company management reviewed all material events through the date of issuance and has determined that there are no material subsequent events to report.

Item 2. Management’sManagements Discussion and Analysis of Financial StatementsCondition and Results of Operations


Throughout this quarterly report, unless the context indicates otherwise, the terms, “we,” “us,” “our” or the “Company” refer to Pacific Health Care Organization, Inc., (“PHCO”) and our wholly-owned subsidiaries Medex Healthcare, Inc. (“Medex”), Medex Managed Care, Inc. (“MMC”) and Medex Medical Management, Inc. (“MMM”), and, where applicable, our former subsidiaries Industrial Resolutions Coalition (“IRC”) Medex Legal Support, Inc. (“MLS”) and Pacific Medical Holding Company, Inc. (“PMHC”).

This

All statements other than statements of historical fact included herein and in the documents incorporated by reference in this quarterly report on Form 10-Q contains(this “quarterly report”), if any, including without limitation, statements regarding our future financial position or results of operations, business strategy, potential acquisitions, budgets, projected costs, and plans and objectives of management for future operations, are forward-looking statements within the meaning of Section 27A of the Private Securities Litigation Reform Act of 1933, as amended (the “Securities Act”) and Section 21E of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), that are based on our management’s beliefs and assumptions and on information currently available to them.  For this purpose any statement contained in this report that is not a statement of historical fact may1995. In some cases, forward-looking statements can be deemed to be forward-looking, including statements about our revenue, spending, cash flow, products, new customer acquisitions, trends, actions, intentions, plans, strategies and objectives.  Without limiting the foregoing, wordsidentified by terminology such as “anticipate,” “believe,” “continue,” “could,” “estimate,” “expect,” “forecast,” “foresee,” “future,” “intend,” “likely,” “may,” “hope,“might,” “plan,” “potential,” “predict,” “project,” “should,” “strategy,” “will,” “expect,“would,“believe,” “anticipate,” “estimate,” “project,” “intend,” “budget,” “plan,” “forecast,” “predict,” “could,” “should,” or “continue” or comparable terminology are intended to identify forward-looking statements.  These statements byand other similar expressions and their nature involve substantial risk and uncertainty, and actual results may differ materially depending on a variety of factors, many of which are not within our control.  These factors include but are not limited to economic conditions generally and in the industry in which we and our customers participate; cost reduction efforts by our existing and prospective customers; competition within our industry, including competition from much larger competitors; business combinations; legislative requirements or changes which could render our services less competitive or obsolete; our failure to successfully develop new services, and/or products or to anticipate current or prospective customers’ needs; our ability to retain existing customers and to attract new customers; price increases; employee limitations; and delays, reductions, or cancellations of contracts we have previously entered.negatives.


Forward-looking statements are predictions and not guarantees of future performance and involve known and unknown risks and uncertainties, many of which may be beyond our control. Readers are cautioned not to place undue reliance on forward-looking statements, which speak only as of the date hereof, and actual results could differ materially as a result of various factors. The following include some but not all of the factors that could cause actual results or events.events to differ materially from anticipated results or events:

competition within our industry, including competition from much larger competitors;

reductions in worker’s compensation claims or the demand for our services, from whatever source;

cost reduction efforts by our existing and prospective customers;

our ability to retain existing customers and to attract new customers;

delays, reductions, or cancellations of contracts we have previously entered;

the loss, ineffective management, malfunction (including those resulting from cybersecurity incidences and breaches), or increased costs of third-party-provided technologies and services on which our operations rely;

the loss of or inability to obtain adequate insurance coverage;

cybersecurity incidences and breaches, and other software system failures, and the imposition of laws imposing costly cybersecurity and data protection compliance;

business combinations involving our customers or competitors;

economic and labor market conditions generally and in the industries in which we and our customers participate, including the effects resulting from economic recessions, financial sector turmoil, international conflicts, and rising domestic inflation and related economic policy responses;

the impacts on our business of COVID-19, including the reduction of our customers’ workforces as a result of a variety of COVID-19-related causes, as well as government mandates and impacts on the workers’ compensation industry, the businesses of our customers and on the economy generally;

legislative and regulatory requirements or changes which could render our services less competitive or obsolete; and

our failure to successfully develop new services and/or products either organically or through acquisition, or to anticipate current or prospective customers’ needs.

For more detailed information about particular risk factors related to us and our business, see Item 1A Risk Factors of our Annual Report on Form 10-K for the year ended December 31, 2022, filed with the Securities and Exchange Commission (the “Commission”) on March 31, 2023 (our “Annual Report”).

We operate in a competitive and rapidly changing environment. New risk factors emerge from time to time, and it is not possible for our management to predict all risk factors, nor can we assess the impact of all factors on our business or the extent to which any factor, or combination of factors, may cause actual results to differ materially from those contained in any forward-looking statements.

One should not place undue reliance on forward-looking statements. Forward-looking statements are based on current industry, financialthe beliefs of management as well as assumptions made by and economic information which we have assessed but which, by its nature, is dynamiccurrently available to management and subject to rapid and possibly abrupt changes.  Our actual results could differ materially from those stated or implied by such forward-looking statements due to risks and uncertainties associated with our business.  We hereby qualify all our forward-looking statements by these cautionary statements. These forward-looking statements speakapply only as of theirthe date of this quarterly report or the respective dates and should not be relied upon.  Weof the documents from which it incorporates by reference. Neither we nor any other person assumes any responsibility for the accuracy or completeness of forward-looking statements. Further, except to the extent required by law, we undertake no obligationobligations to publicly update or revise any forward-looking statements, whether as a result of new information, future events, or otherwise (other than pursuanta change in events, conditions, circumstances, or assumptions underlying such statements, or otherwise. We may also make additional forward-looking statements from time to reporting obligations imposedtime. Any subsequent forward-looking statements, whether written or oral, made by us or on registrants pursuant to the Exchange Act) to reflect subsequent events or circumstances.our behalf, are also expressly qualified by these cautionary statements.


The following discussion should be read in conjunction with our unaudited condensed consolidated financial statements and the related notes contained elsewhere in this quarterly report and in our other filings with the Commission.


Overview

Throughout this quarterly report on Form 10-Q, unless

We incorporated under the context indicates otherwise,laws of the terms, “we,” “us,” “our” or “the Company” referstate of Utah in April 1970, under the name Clear Air, Inc. We changed our name to Pacific Health Care Organization, Inc., in January 2001. In February 2001, we acquired Medex, a California corporation organized in March 1994, in a share for share exchange. Medex is in the business of managing and administering both Health Care Organizations (“PHCO”HCOs”) and Medical Provider Networks (“MPNs”) in the state of California. In August 2001, we formed IRC, a California corporation, as a wholly owned subsidiary of PHCO. Prior to closing IRC, IRC oversaw and managed our wholly-ownedworkers’ compensation carve-outs services. In June 2010, we acquired MLS, a Nevada corporation incorporated in September 2009. Prior to closing MLS, MLS offered lien representation services and Medicare set-aside services (“MSA”). In March 2011, we incorporated MMC, a Nevada corporation, as a wholly owned subsidiary of the Company. MMC oversees and manages the Company’s utilization review and bill review services. In February 2012, we incorporated MMM, a Nevada corporation, as a wholly owned subsidiary of the Company. MMM is responsible for overseeing and managing medical case management services. In October 2018, we incorporated PMHC, a Nevada corporation, as a wholly owned subsidiary of the Company to act as a holding company for future potential acquisitions.

In October 2021, we terminated the existence of IRC, MLS and PMHC and wound up those subsidiaries in an effort to simplify business procedures, bookkeeping and administrative structure, eliminate duplicative functions, and reduce costs. The business, assets, liabilities, and services of those entities were transferred to PHCO or its other subsidiaries. Medex Healthcare, Inc. (“Medex”), Industrial Resolutions Coalition, Inc. (“IRC”), Medex Managed Care, Inc. (“MMC”), Medex Medical Management, Inc. (“MMM”)now offers our workers’ compensation carve-out services previously provided by IRC and Medex Legal Support, Inc. (“MLS”).Medicare set-aside previously managed by MLS. As of the third quarter of 2023, we have discontinued lien representation services due to lack of customer demand and resources.


Business of the Company

Overview


We offer an integrated and layered array of complementary business solutions that enable our customers to better manage their employee workers’ compensation-related healthcare administration costs. We are workers’ compensation cost containment specialists.  constantly looking for ways to expand the suite of services we can provide our customers, either through strategic acquisitions or organic development.

Our business objective is to deliver value to our clients that reducescustomers by reducing their workers’ compensation relatedcompensation-related medical claims expense in a manner that will assure that injured employees receive high quality healthcare that allows them to recover from an injury and return to gainful employment without undue delay. According to studies conducted by auditing bodies on behalf of the California Division of Workers’ Compensation, (“DWC”) the two most significant cost drivers for workers’ compensation are claims frequency and longer than average treatment duration. Our services focus on ensuring timely medical treatment to reduce the claim duration and medical treatment costs.

8

Our services include providing customers access to our HCOs and MPNs. We also provide medical bill review, medical case management, employee advocate services, utilization review, workers’ compensation carve-outs, and Medicare set-aside services. Complementary to these services, we also provide expert witness testimony. We offer our services as a bundled solution, as standalone services, or as add-on services.




Our core service focusesservices focus on the reduction ofreducing medical treatment costs by enabling our client/employerscustomers to share thehave control overand oversight of the medical treatment process.of their injured employees to ensure treatment is timely and appropriate. This control is primarily obtained by participation in our HCOs or one of our medical treatment networks.  We hold several valuable government-issued licenses to operate medical treatment networks.MPNs. Through Medex, we hold two of the total of ninefour licenses issued by the Statestate of California to establish and manage a Health Care Organization (“HCO”)HCOs within the state of California. We hold several government-issued licenses to operate medical provider networks. We also hold approvals issued by the Statestate of California to act as a Medical Provider Network (“MPN”).an MPN and currently administer 21 MPNs. Our HCO and MPN programs provide our client/employerscustomers with provider networks within which the client/employercustomer has some ability to direct the administration of the claim. This is designed to decrease the incidence of fraudulent claims and disability awards and ensure injured employees receive the necessary back-to-workvocational rehabilitation and training they need.  We also offer a Nurse Case Management program that keepstraining. Our medical bill and utilization review services provide oversight of medical billing and treatment requests, and our medical case management and employee advocate services keep workers’ compensation claims progressing to a resolution and assures treatment plans are aligned from a medical perspective.  Nurse oversight is a collaborative process that assesses plans, implements, coordinates, monitors and evaluates the options and services required to meet an injured worker’s health needs.

Our clientscustomers include self-administered employers, insurers, third party administrators, municipalities, and others. Our principal clientscustomers are companies with operations located in the Statestate of California where the high cost of workers’ compensation insurance is a critical problem for employers.employers, though we process medical bill reviews, utilization reviews and provide medical case management in several other states. Our provider networks, which are located only in California, are composed of providers experienced in treating worker injuries.

Our business generally has a long sales cycle, typically eight months or more. Once we have contractedestablished a customer relationship and enrolled the employees of our employer customers, we anticipate our revenue to adjust with approximately 3,900 individualthe growth or retraction of our customers’ employee headcount. Throughout the year, we also expect to add new customers while others terminate for a variety of reasons. The reasons for termination vary but include when a customer switches to an insurance carrier or third party administrator that uses a different workers’ compensation administration vendor, or when our contract ends with state and local governments.

Key trends affecting results of operations

During the nine months ended September 30, 2023 and 2022, COVID-19 continued to impact the businesses of our customers and our results of operations. For example, in the first quarter of 2022, our customers had a relatively large increase in COVID-19 workers’ compensation claims due to the seasonality of the illness and as the economy opened back up and employees returned to their workplaces. Our HCO customers’ industries generally have a higher risk of exposure to COVID-19 and thus reported a greater number of COVID-19 claims. As a result, COVID-19 claims remained elevated in the first nine months of 2022. Our MPN customers, whose industries were at a relatively lower risk for COVID-19 exposure had a large increase in reported COVID-19 claims in the first quarter of 2022 but began to return to pre-pandemic levels during the second quarter of 2022. During the first three quarters of 2023, COVID-19 claims have remained low and we have realized minimal related revenues, as a result. We anticipate that revenues related to COVID-19 will remain low through the remainder of 2023.

During 2022, the increased volume of COVID-19 workers’ compensation claims resulted in temporary increases in our revenues generated from claim network and medical providerscase management fees, particularly during the first quarter of 2022. However, that trend began reversing during the second quarter of 2022 as the severity and clinics,frequency of the illness declined and California Sick Paid Leave “CSPSL” ended paid time off for COVID-19 related illnesses, which we believe also has contributed to lower reporting of COVID-19 claims.

The relative decline in COVID-19 workers’ compensation claims resulted in lower revenues generated from HCO and MPN claim network and medical case management fees when comparing the three- and nine-month periods of 2023 with 2022. We do not expect further material declines in COVID-19 workers’ compensation claims and related revenues as the current level of new COVID-19 claims is minimal.

During the third quarter of 2023, we saw an increase in the number of employees enrolled in our HCO and MPN programs. The enrollment numbers in our HCO and MPN programs generally correlate with economic conditions and the size and activities of our customers’ workforce. If economic conditions become challenging, including from the effects of inflationary pressures, elevated interest rates, and challenging labor market conditions, our customers may reduce their workforce, in which case we would expect a decline in the number of employees enrolled in our HCO and MPN programs in future periods and in related revenues.

During the fourth quarter of 2022 and through the first quarter of 2023, we experienced difficulties transitioning to a new software vendor for our utilization review and medical case management services. Throughout the software transition, our automated processes had to be performed manually, which caused delays in providing services and invoicing our customers, reduced productivity and resulted in additional outsourcing costs. Our net income was adversely impacted in the first quarter of 2023 as a result of the interruptions and costs associated with the software transition. However, during the third quarter of 2023 the issues were resolved. As of the date of this quarterly report, the delayed invoicing problems have been addressed and much of the related outstanding accounts receivable has decreased.

As previously disclosed in our Annual Report, Fortra, LLC, the third-party vendor that provides the GoAnywhere managed file transfer as a service system (MFTaaS), experienced a data security incident that affected many of Fortra’s customers, including the Company. As of the date of this quarterly report, this incident has not caused a material interruption of our business operations. We are in the process of providing appropriate notifications to the individuals affected by the incident, as well as hospitals, pharmacies, rehabilitation centersto various State Attorneys General. We have incurred expenses, and may incur in the future expenses and losses, related to this incident, some of which may not be covered by cyber liability insurance. Further, because of the ongoing nature of the effects of this incident and current unknowns, an estimate of the impact on our business, results of operations and other ancillary services enabling our networks to provide comprehensive medical services throughout California.  Our provider networks are composedpotential liabilities cannot be made.


Beyond the core services we provide to facilitate client/employer involvement in employee medical treatment claims administration and patient treatment options, we also provide

Revenue

We derive revenue from fees charged for access to our HCO and MPN clients a number of claims-related services that bring efficiencies toprovider networks, claim processing and management that further reduce the overall burden of workers’ compensation claims resolution.  These services include various back office type functions that assure cost efficiency and accuracy in claim processing, claim reimbursement and claim dispute resolution.


Recent Developments

network fees, HCO/MPN Enrollment Count
Changes to the MPN regulations in August 2014 eliminated the notice requirements to employees covered under an MPN program.  This change eliminated the need for our MPN clients to submit employee rosters for MPN notice mailings.  As a result, over the past several years, many of our MPN client/employers have stopped sending us employee rosters which we have historically used to determine employee/enrollee headcount information.  Enough of our MPN client/employers have stopped submitting to us such information that we can no longer accurately track the overall number of MPN participants.  Therefore, beginning in the first quarter 2017, we ceased tracking the overall number of MPN participants of all client/employers in our MPN program.
HCO Enrollment Count

 Historically, the HCO employee/enrollee headcount was directly related to the amount of revenue generated by HCO clients.  We were, however, at risk of losing several clients under this pricing model.  To remain competitive in the marketplace, we developed a new pricing model, which includes both a fixed monthly flat rate pricing option that is negotiated per client and/or a per claim incurred pricing model.  Under the per claim model, our client/employers do not incur this cost as an out of pocket cost, but rather apply the cost directly to the insured or self-insured claim.  As a result of moving from our fixed fee per number of employee/enrollees per customer model, beginning in the first quarter 2017 we have discontinued reporting the direct relationship between the number of HCO employee/enrollees and total HCO revenues because that historical relationship has become distorted as a result of the implementation of our new pricing model. This change in our pricing model had no significant impact to our current level of HCO revenues and we expect the same level of impact over the remaining months of 2017.

Results of Operations

Comparison of the three months ended September 30, 2017 and 2016

The following represents selected components of our consolidated results of operations, for the three-month periods ended September 30, 2017 and 2016, respectively, together with changes from period-to-period:
  For three months ended September 30,       
  2017  2016  Amount Change  % Change 
Revenues:            
HCO fees $377,923  $276,951  $100,972   36%
MPN fees  142,257   146,836   (4,579)  (3%)
NCM fees  582,544   499,118   83,426   17%
UR fees  277,886   221,176   56,710   26%
MBR fees  147,094   187,829   (40,735)  (22%)
Other  73,203   111,686   (38,483)  (34%)
Total revenues  1,600,907   1,443,596   157,311   11%
                 
Expense:                
Depreciation and amortization  19,462   20,925   (1,463)  (7%)
Bad debt provision  15,750   4,500   11,250   250%
Consulting fees  90,079   75,228   14,851   20%
Salaries and wages  547,963   574,100   (26,137)  (5%)
Professional fees  109,064   82,105   26,959   33%
Insurance  79,489   81,452   (1,963)  (2%)
Outsource service fees  146,287   113,017   33,270   29%
Data maintenance  12,160   30,160   (18,000)  (60%)
General and administrative  162,164   157,894   4,270   3%
Total expenses  1,182,418   1,139,381   43,037   4%
                 
Income from operations  418,489   304,215   114,274   38%
                 
Income before taxes  418,489   304,215   114,274   38%
Income tax provision  174,560   126,882   47,678   38%
                 
 Net income $243,929  $177,333  $66,596   38%

Revenue

Total revenues during the three-month period ended September 30, 2017, increased 11% to 1,600,907 compared to $1,443,596 during the three-month period ended September 30, 2016.
During the third quarter 2017, HCO, nursenetwork administration, medical bill review, medical case management and employee advocate, utilization review, increased 36%, 17%,Medicare set-asides, and 26% respectively, whilenetwork access.

HCO

HCO revenue is generated from fees charged to our employer customers for claim network fees to access our HCO networks, employee enrollment into our HCO program, program administration, custom network fees, annual and new hire notifications, and fees for other ancillary services they may select.

MPN

Like HCO revenue, MPN revenue is generated from fees charged to our employer customers for claim network fees to access our MPN networks, custom network fees, MPN notifications, and program administration. Unlike HCOs, from which we derive revenues from annual and new hire notification fees, MPNs do not require annual and new hire notifications and as such we do not generate related revenues. Rather, MPN notification revenues are limited to the required notices to an injured employee at the time the employer is notified by the injured employee that an injury occurred.

Medical Bill Reviewbill review

California and many other states have established fee schedules for the maximum allowable fees decreased by 3%, 22% and 34%, respectively.  Other revenues consisted of revenues derived primarily from network claims repricing services, lien representation services, legal support services,payable under workers’ compensation carve out revenues and Medicare set aside revenues.


HCO fees

Duringfor a variety of procedures performed by medical providers. Many procedures, however, are not covered under the three-month periods ended September 30, 2017 and 2016, HCO fee revenues were $377,923 and $276,951, respectively.  The 36% increase in HCO revenue was primarily attributable to increased revenues derived from one major client during the third quarter of 2017, coupled with increased fees primarily from three other existing customers.

MPN fees

MPN fee revenue for the three-month periods ended September 30, 2017 and 2016, were $142,257 and $146,836, respectively, a decrease of 3%, resulting mainly from lower revenues from one existing customer.

NCM fees

During the three months ended September 30, 2017 and 2016, nurse case management revenue was $582,544 and $499,118, respectively.  The increase in nurse case management revenue of $83,426 was primarily from increased revenues from five existing customers when compared to the same period in 2016.  There is no assurance that nurse case management revenue will continue to grow at the rate realized in the quarter ended September 30, 2017 for the remaining months of fiscal 2017.

UR fees

During the three-month periods ended September 30, 2017 and 2016, utilization review revenue was $277,886 and $221,176 respectively.  The increase of $56,710 in the 2017 period was primarily attributable to adding two new clients in the fourth quarter of fiscal 2016 and increases in revenues from other existing customers.  Utilization review can provide a safeguard against unnecessary and inappropriate medical treatment from the perspective of medical necessity, quality of care, appropriateness of decision-making, etc.   Through our skilled staff and automated review system, we are able to deliver utilization review services that cut overhead costs for the self-insured clients, insurance companies and the public entities we service. 

MBR fees

During the three-month period ended September 30, 2017, medical bill review revenue decreased $40,735 to $147,094 when compared to the same period a year earlier.  This decrease was mainly caused by processing fewerschedules, such as hospital bills, from existing customers.which still require review and negotiation. Medical bill review involves analyzing medical provider services and equipment billing to ascertain proper reimbursement. Such services include, but are not limited to, coding review and rebundling, confirming that the services are customary and reasonable, fee schedule compliance, out-of-network bill review, pharmacy review, and preferred provider organization repricing arrangements.  These services can result in significant network savings. 

Other

Other fees consist of revenue derived from network access and claims repricing, lien representation, legal support services, Medicare set aside and worker’s compensation carve-out services.  Other fee revenue for three-month periods ended September 30, 2017 and 2016, were $73,203 and $111,686 respectively. The decrease of $38,483 was mainly the result of decreased network access fees from one customer having realized lower levels of savings from using our PPO network. We expect this downward trend for this customer to continue for the remainder of 2017.

Expenses
Total expenses for the three months ended September 30, 2017 and 2016, were $1,182,418 and $1,139,381, respectively.  The increase of $43,037 was the result of increases in bad debt provision, consulting fees, professional fees, outsource service fees, and general and administrative expense partially offset by decreases in depreciation and amortization, salaries and wages, and data maintenance expense.

Depreciation and Amortization

During the three-month period ended September 30, 2017, we recorded depreciation and amortization expense of $19,462 compared to $20,925 during the comparable 2016 period.  The decrease in depreciation and amortization was primarily attributable to certain fixed assets being fully depreciated during the fourth quarter of 2016.

Bad Debt

During the three-month period ended September 30, 2017, bad debt provision increased by $11,250 compared to the three-month period ended September 30, 2016.  This increase was primarily the result of recording additional bad debt provision for one existing uncollectable account.

Consulting Fees

During the three months ended September 30, 2017, consulting fees increased to $90,079 from $75,228 during the three months ended September 30, 2016.   This increase was primarily the result on hiring a consultant as Director of Medical Management in August 2017.

Salaries and Wages

During the three-month period ended September 30, 2017, salaries and wages decreased 5% to $547,963 compared to $574,100 during the same period in 2016. The decrease in salaries and wages of $26,137 was primarily the result of lower deferred compensation expense, payroll related taxes, commission expense and lower levels of other salaries and wages in Medex and PHCO.

Professional Fees

For the three months ended September 30, 2017, we incurred professional fees of $109,064 compared to $82,105 during the three months ended September 30, 2016.  The $26,959 increase in professional fees was primarily the result of higher accounting expense, legal expenses, medical consultant fees and professional fees paid for nurse case management services resulting from increased numbers of cases processed.

Insurance

During the three-month period ended September 30, 2017, we incurred insurance expenses of $79,489, a 2% decrease over the same three-month period in 2016.  This decrease in insurance expense was primarily attributable to lower group health insurance premiums resulting from a decreased number of employees when compared to the same period in 2016.  We do not expect current insurance fees to increase significantly over the remaining months of 2017.

Outsource Service Fees

Outsource service fees consist of costs incurred by our subsidiaries in outsourcing utilization review,Our medical bill review Medicare set aside services and field case management fees and typically tends to increase and decrease in correspondence with increases and decreases in demand for those services.  We incurred $146,287 and $113,017 in outsource service fees during the three-month periods ended September 30, 2017 and 2016, respectively.  The increase of $33,270 was primarily the result of increases in outsource services required for utilization review, Medicare set aside services and nurse case management.  We anticipate our outsource service fees will continue to move in correspondence with the level of utilization review, medical bill review and certain nurse case management services we provide in the future.  


Data Maintenance

During the three-month periods ended September 30, 2017 and 2016, data maintenance fees were $12,160 and $30,160, respectively.  The decrease of $18,000 was primarily the result of lower levels of customer notifications fees realized for new and existing customers during the three-month period ended September 30, 2017 when compared to the same period in 2016.  Data maintenance fees tend to fluctuate from month to month depending on when new customers are enrolled and when the annual renewal of existing customer notification are due.

General and Administrative
During the three-month period ended September 30, 2017, general and administrative expenses increased 3% to $162,164 when compared to the three-month period ended September 30, 2016.  This increase of $4,270 was primarily attributable to increases in auto expense, dues and subscriptions, employment agency fees, IT enhancements, rental equipment, telephone expense and travel and entertainment expense, partially offset by decreases in office rent expense, office supplies, postage expense, paid time off expense and miscellaneous expenses.  We do not expect current levels of general and administrative expenses to materially increase during the remaining months of 2017.

Income from Operations

As a result of the 11% increase in total revenue during the three-month period ended September 30, 2017, which was partially offset by the 4% increase in total expenses during the same period, our income from operations increased by 38% during the three-month period ended September 30, 2017, when compared to the same period in 2016. 

Income Tax Provision

Because we realized income before taxes of $418,489 and $304,215 during the three-month periods ended September 30, 2017 and 2016, respectively, we realized a $47,678, or 38%, increase in our income tax provision. 

Net Income

During the three-month period ended September 30, 2017, total revenues of $1,600,907 was 11% higher when compared to the same period in 2016.  This increase in total revenues was partially offset by a 4% increase in total expenses, resulting in a 38% increase in income from operations compared to the three months ended September 30, 2016.  Correspondingly, we realized net income of $243,929 for the three-month period ended September 30, 2017, also a 38% increase compared to the three-month period ended September 30, 2016. 


Comparison of nine months ended September 30, 2017 and 2016

The following represents selected components of our consolidated results of operations, for the nine-month periods ended September 30, 2017 and 2016, respectively, together with changes from period-to-period:

  For nine months ended September 30,       
  2017  2016  Amount Change  % Change 
Revenues:            
HCO fees $1,041,328  $965,768  $75,560   8%
MPN fees  427,228   436,893   (9,665)  (2%)
NCM fees  1,824,121   1,176,447   647,674   55%
UR fees  788,229   596,205   192,024   32%
MBR fees  481,352   517,893   (36,541)  (7%)
Other  255,542   309,260   (53,718)  (17%)
Total revenues  4,817,800   4,002,466   815,334   20%
                 
Expense:                
Depreciation and amortization  58,859   63,247   (4,388)  (7%)
Bad debt provision  30,500   13,500   17,000   126%
Consulting fees  246,073   265,296   (19,223)  (7%)
Salaries and wages  1,734,321   1,717,148   17,173   1%
Professional fees  308,295   224,368   83,927   37%
Insurance  257,495   243,307   14,188   6%
Outsource service fees  404,538   288,225   116,313   40%
Data maintenance  71,261   113,175   (41,914)  (37%)
General and administrative  495,474   475,230   20,244   4%
Total expenses  3,606,816   3,403,496   203,320   6%
                 
Income from operations  1,210,984   598,970   612,014   102%
                 
Income before taxes  1,210,984   598,970   612,014   102%
Income tax provision  504,318   249,529   254,789   102%
                 
 Net income $706,666  $349,441  $357,225   102%

Revenue

Total revenues during the nine-month period ended September 30, 2017, increased 20% to 4,817,800 compared to $4,002,466 during the nine-month period ended September 30, 2016.

During the first nine-months of 2017, HCO, nurse case management, and utilization review, increased 8%, 55% and 32% respectively, while MPN, MBR and other fees decreased by 2%, 7%, and 17%, respectively.  Other revenues consisted of revenues derived primarily from network claims repricing services, lien representation services, legal support services, workers’ compensation carve out revenues and Medicare set aside revenues.

HCO fees

During the nine-month periods ended September30, 2017 and 2016, HCO fee revenues were $1,041,328 and $965,768 respectively. The 8% increase in HCO revenue was primarily attributable to the addition of one major customer in January 2017, partially offset by lower revenues from several existing HCO customers when compared to the same period in 2016


MPN fees

MPN fee revenue for the nine-month periods ended September 30, 2017 and 2016, was $427,228 and $436,893 respectively, a decrease of 2%, resulting from lower revenues from one existing customer. 

NCM fees
During the nine-months ended September 30, 2017 and 2016, nurse case management revenue was $1,824,121 and $1,176,447, respectively.  The increase in nurse case management revenue of $647,674 was primarily the result of adding new customers during the third and fourth quarters of 2016, and increases in revenues from existing customers.  As a result of losing a significant customer in October 2017, we do not expect nurse case management revenue to increase at the rate realized during the nine months ended September 30, 2017, for the remainder of fiscal 2017.

UR fees

During the nine-month periods ended September 30, 2017 and 2016, utilization review revenue was $788,229 and $596,205, respectively.  The increase of $192,024 in the 2017 period was attributable to adding new clients in the third and fourth quarters of fiscal 2016.  Utilization review can provide a safeguard against unnecessary and inappropriate medical treatment from the perspective of medical necessity, quality of care, appropriateness of decision-making, etc.   Through our skilled staff and automated review system, we are able to deliver utilization review services that cut overhead costs for the self-insured clients, insurance companies and the public entities we service. 
MBR fees

During the nine-month period ended September 30, 2017, medical bill review revenue decreased $36,541 to $481,352 when compared to the same period a year earlier.  This 7% decrease was mainly caused by processing fewer hospital claims from existing customers.  Medical bill review involves analyzing medical provider services and equipment billing to ascertain proper reimbursement.  Such services include but are not limited to, coding review and re-bundling, confirming that the services are customary and reasonable, fee schedule compliance, out-of-network bill review, pharmacy review, and preferred provider organization repricing arrangements. TheseOur medical bill review services can result in significant network savings. savings for our customers. Revenue for medical bill reviews is generated based on a set fee per medical bill reviewed and a percentage of savings of the preferred provider organization (PPO) discounts. Hospital bill review services generate revenue on a percentage of savings off of the hospital bill, usually with a negotiated cap.


Medical case management

Medical case management oversees the injured employees’ medical treatment to ensure that it progresses to a resolution and assures treatment plans are aligned from a medical perspective. Medical oversight is a collaborative process that assesses, evaluates, coordinates, implements and monitors medical treatment plans and the options and services required to meet an injured worker’s health needs. Our medical case management services are performed by nurses who are credentialed by the state and have expertise in various clinical areas and backgrounds in workers’ compensation matters. We work to manage the number of nurses in our program to maintain our ratio of claims per nurse at a level that ensures timely and appropriate medical care is given to the injured worker and facilitates faster claim closures for our customers. We also offer employee advocate services, which is similar to medical case management in that it utilizes our medical case managers who provide similar services; however, the medical case manager is an advocate of the employee. We generate revenue from these services when we receive a workers’ compensation claim and a medical case manager is assigned to oversee the injured workers’ medical treatment, with billing based on the number of hours a medical case manager works on the claim.

Utilization review

Utilization review is the review of medical treatment requests by providers to provide a safeguard for employers and injured employees against unnecessary or inappropriate medical treatment from the perspective of medical necessity, quality of care, appropriateness of decision-making, and timeliness of treatment. Its purpose is to reduce employer liability for medical costs that are not medically appropriate or approved by the relevant medical and legal authorities and the payor. We generate revenue when we receive a referral for a request for authorization of treatment from a claims adjuster. We bill by the number of treatment requests and the level of expertise of the reviewer required to approve, modify, or deny the request.

Other


Other fees consistrevenue consists of revenue derived from network access and claims repricing, lien representation,fees charged for network access for preferred provider organizations, ancillary legal support services, Medicare set asideset-aside and worker’sworkers’ compensation carve-outscarve-out services.  Other fee revenue

The following table sets forth, for the three- and nine-month periods ended September 30, 20172023 and 2016, was $255,5422022, respectively, the percentage each revenue item identified in our unaudited condensed consolidated financial statements contributed to total revenues during the respective period.

  

For the three months ended

  

For the nine months ended

 
  

September 30,

  

September 30,

 
  

2023

  

2022

  

2023

  

2022

 

HCO

  27

%

  24

%

  24

%

  23

%

MPN

  10

%

  9

%

  10

%

  10

%

Medical bill review

  6

%

  7

%

  7

%

  8

%

Medical case management

  21

%

  26

%

  23

%

  28

%

Utilization review

  33

%

  31

%

  34

%

  29

%

Other

  3

%

  3

%

  2

%

  2

%

Expense

Consulting fees

Consulting fees include fees we pay to third parties for IT, marketing, lobbying, and $309,260, respectively. The decrease of $53,718 was mainlyin-house legal services related to the result of decreased network access fees from one customer having realized lower savings from using our PPO network. We expect this downward trend for this customer to continue for the remainder of 2017.various services we offer.


Expenses
Total expenses for the nine-months ended September 30, 2017

Salaries and 2016, were $3,606,816 and $3,403,496, respectively.  The increase of $203,320 was the result of increases in bad debt, salarieswages

Salaries and wages professionalreflect employment-related compensation we pay to our employees, payroll processing, payroll taxes and commissions.

Professional fees insurance, outsource service

Professional fees and general and administrative expense, partially offset by decreases in depreciation and amortization,include fees we pay to third parties to provide medical consulting, fees and data maintenance expense.


Depreciation and Amortization
During the nine-month period ended September 30, 2017, we recorded depreciation and amortization expense of $58,859 compared to $63,247 during the comparable 2016 period.  The decrease in depreciation and amortization was primarily attributable to certain fixed assets being fully depreciated during the fourth quarter of 2016.

Bad Debt

During the nine-month period ended September 30, 2017, bad debt provision increased by $17,000 compared to the nine-month period ended September 30, 2016.  This increase was primarily the result of additional provisions required for one potential uncollectable account.

Consulting Fees

During the nine-months ended September 30, 2017, consulting fees decreased to $246,073 from $265,296, when compared the nine months ended September 30, 2016.   This 7% decrease was mainly the result of a reduction in fees paid to two consultants commencing in June 2016 and converting a consultant to an employee in March 2016.
Salaries and Wages

During the nine-month period ended September 30, 2017, salaries and wages increased 1% to $1,734,321 compared to $1,717,148 during the same period in 2016.  This increase was primarily the result of additional staffing in nursefield medical case management, and higher levelsboard of commissions, partially offset by salary reductionsdirectors’ fees for board meetings, as well as legal, accounting, and other professional services fees.

Insurance

Insurance expenses are comprised primarily of 10% by several senior executives in June 2016.


Professional Fees

For the nine-months ended September 30, 2017, we incurred professional fees of $308,295 comparedhealth insurance benefits offered to $224,368 during the nine months ended September 30, 2016.   The $83,927 increase in professional fees was primarily the result of higher professional fees paid for nurse case management services resulting from increased numbers of cases processed.

Insurance

During the nine-month period ended September 30, 2017, we incurred insurance expenses of $257,495, a 6% increase over the same nine-month period in 2016.  The increase in insurance expense was primarily attributed to higher workers’ compensation premiums for our employees, and directors’ and officers’ liability insurance, premiums during the nine months period ended September 30, 2017 compared to the same period in 2016. We do not expect current insurancecyber security, workers’ compensation coverage and business liability coverage.

Outsource service fees to increase significantly over the remaining months of 2017.


Outsource Service Fees

Outsource service fees consist of costs incurred by our subsidiaries inby partially outsourcing utilization review, medical bill review, Medicare set asideadministrative services nursefor medical case management and HCO, and Medicare set-aside services, and typically tendstend to increase and decreasefluctuate in correspondencecorrelation with increases and decreases incustomer demand for those services.  We incurred $404,538

Data maintenance fees

Data maintenance fees include fees we pay to a third party to process HCO employee enrollments and $288,225MPN notices. HCO employee enrollment and MPN notification fees fluctuate throughout the year because of the varied timing of customer enrollment into our HCO program, the number of employees our customers have in their workforce, the number of new hires throughout the year, and the number of new workers’ compensation claims.

General and administrative

General and administrative expenses consist primarily of office rent, advertising, dues and subscriptions, equipment/repairs, IT enhancement, licenses and permits, telephone, office supplies, parking, postage, printing and reproduction, miscellaneous expenses, shareholders’ expense, charity – cash contribution, auto expenses, bank charges, education, travel and entertainment, and vacation expense.

The following table sets forth, for the three- and nine-month periods ended September 30, 2023 and 2022, respectively, the percentage each expense item identified in our unaudited condensed consolidated financial statements contributed to total expenses during the respective period.

  

For the three months ended

  

For the nine months ended

 
  

September 30,

  

September 30,

 
  

2023

  

2022

  

2023

  

2022

 

Depreciation

  -

%

  1

%

  1

%

  1

%

Bad debt provision

  -

%

  -

%

  -

%

  -

%

Consulting fees

  5

%

  5

%

  5

%

  4

%

Salaries and wages

  52

%

  59

%

  53

%

  56

%

Professional fees

  7

%

  6

%

  7

%

  6

%

Insurance

  7

%

  7

%

  6

%

  7

%

Outsource service fees

  15

%

  13

%

  15

%

  12

%

Data maintenance fees

  -

%

  -

%

  2

%

  2

%

General and administrative

  14

%

  9

%

  11

%

  12

%

Results of Operations

Comparison of the three months ended September 30, 2023 and 2022

The following represents selected components of our consolidated results of operations for the three-month periods ended September 30, 2023 and 2022, respectively, together with changes from period-to-period:

  

For three months ended

September 30,

         
  

2023

  

2022

  

Amount Change

  

% Change

 

Revenues:

                

HCO

 $373,280  $354,913  $18,367   5

%

MPN

  132,403   128,297   4,106   3

%

Medical bill review

  90,988   99,418   (8,430

)

  (8

%)

Medical case management

  292,195   384,657   (92,462

)

  (24

%)

Utilization review

  451,167   443,049   8,118   2

%

Other

  36,006   43,663   (7,657

)

  (18

%)

Total revenues

  1,376,039   1,453,997   (77,958

)

  (5

%)

                 

Expenses:

                

Depreciation

  8,936   9,661   (725

)

  (8

%)

Bad debt provision

  1,265   (5,520

)

  6,785   123

%

Consulting fees

  56,418   56,148  

270

   -

%

Salaries and wages

  638,288   699,026   (60,738

)

  (9

%)

Professional fees

  89,677   76,065   13,612   18

%

Insurance

  81,003   79,974   1,029   1

%

Outsource service fees

  180,579   156,677   23,902   15

%

Data maintenance

  4,524   2,898   1,626   56

%

General and administrative

  168,344   112,135   56,209   50

%

Total expenses

  1,229,034   1,187,064   41,970   4

%

                 

Income from operations

  147,005   266,933   (119,928

)

  (45

%)

                 

Other income (expense)

                

Interest income

  102,017   -   102,017   100

%

Total other income (expense)

  102,017   -   102,017   100

%

                 

Income before taxes

  249,022   266,933   (17,911

)

  (7

%)

Income tax provision

  (69,901

)

  (74,928

)

  5,027   (7

%)

                 

Net income

 $179,121  $192,005  $(12,884

)

  (7

%)

Revenue

HCO

During the three-month period ended September 30, 2023, HCO revenue increased 5% compared to the same period in the prior year. The increase in HCO revenue was primarily due to an increased number of monthly and annual HCO enrollees and related administration and notification fees. The increase was partially offset by decreases in claim network fees for COVID-19 claims as they were minimal in the three-month period ended September 30, 2023, compared to the same period in the prior year; as well as decreases in non-COVID-19 claim network fees.

MPN

MPN revenue for the three-month period ended September 30, 2023, increased 3% compared to the same period in the prior year. The increase in revenue was largely attributable to an increase in monthly MPN enrollees and related administration fees. The increase in MPN revenue was partially offset by decreases in the number of claims from which we generate claim network fee revenue.

Medical bill review

During the three-month period ended September 30, 2023, medical bill review revenue decreased 8% compared to the same period in the prior year. The decrease was primarily due to the loss of two customers in the second quarter of 2023 and fewer medical bills reviewed. The decrease was partially offset by the addition of a new customer in the fourth quarter of 2022.

Medical case management

During the three-month period ended September 30, 2023, medical case management revenue decreased 24% compared to the same period in the prior year. The decrease was attributable to a decline in COVID and non-COVID-19 claims from existing customers. During the pandemic, some of our customers opted to have COVID-19 claims assigned to a medical case manager, regardless of severity of the illness, and the trend continued into the third quarter of 2022. Since the third quarter of 2022, due largely to the severity and frequency of COVID-19 claims declining, our customers have stopped requiring a medical case manager to be assigned to those claims, which has adversely impacted medical case management revenues. The decrease in medical case management revenue was partially offset by increases in revenue generated from our employee advocate services.

Utilization review

During the three-month period ended September 30, 2023, utilization review revenue increased 2% compared to the same period in the prior year. The increase in revenue was due to increases in utilization review referrals from existing customers and the addition of a new customer in the fourth quarter of 2022, partially offset by a decrease stemming from the loss of a customer in the second quarter of 2023.

Other

Other revenue for the three-month period ended September 30, 2023, decreased 18% compared to the same period in the prior year. The decrease was mainly attributable to a decrease in the number of referrals for Medicare set-aside. The decrease was partially offset by an increase in network access fee revenue from increased access to our network by preferred provider organizations. 

Expenses

Total expenses for the three-month period ended September 30, 2023, increased 4% compared to the same period in the prior year. The increase was primarily attributable to increases in general and administrative, outsource service fees, professional fees, and bad debt provision, which were partially offset by decreases in salaries and wages.

Depreciation

During the three-month period ended September 30, 2023, depreciation expenses decreased 8% compared to the same period in the prior year. The decrease was primarily due to certain computer equipment fully depreciating.

Bad debt provision

During the three-month period ended September 30, 2023, bad debt provision increased 123% compared to the same period in the prior year stemming from invoice delays related to our utilization review and medical case management software transition, which impacted our ability to collect payments.

Salaries and wages

During the three-month period ended September 30, 2023, salaries and wages decreased 9% compared to the same period in the prior year. The decrease was due to us having fewer employees and was partially offset by an increase in wages and salaries for our existing employees.

Professional fees

During the three-month period ended September 30, 2023, professional fees increased 18% compared to the same period in the prior year. The increase in professional fees was primarily the result of additional legal and accounting services, partially offset by decreases in other professional services and field medical case management fees. The increase in legal services was related to legal fees stemming from a bill dispute and the data security incident during 2023, and the increase in accounting services was related to an employee retention credit, which is a refundable tax credit for businesses and tax-exempt organizations that had employees and were affected during the COVID-19 pandemic.

Outsource service fees

During the three-month period ended September 30, 2023, outsource service fees increased 15% compared to the same period in the prior year. The increase in outsource service fees was primarily attributable to an increased demand for our utilization review and HCO services, the provision of which utilizes outsourced services. The increase was partially offset by decreases in the outsourced services for Medicare set-asides. Our outsourcing and related fees will continue to correspond with the level of medical bill review, utilization review, enrollees in our HCO program, certain field medical case management and Medicare set-aside services.

Data maintenance

During the three-month period ended September 30, 2023, data maintenance fees increased 56% compared to the same period in the prior year. The increase in data maintenance fees was due to increases in our customers’ employee counts for enrollment in our HCO and MPN programs, which have corresponding data maintenance needs.

General and administrative

General and administrative expenses increased 50% during the three-month period ended September 30, 2023 compared to the same period in the prior year. The increase was primarily due to increases in dues and subscriptions, vacation expenses, advertising and marketing, and IT enhancement. The increase was partially offset by decreases in licenses and permits and other general and administrative expenses.

Income from Operations

During the three-month period ended September 30, 2023, income from operations was $147,005, compared to $266,933 during the same period in 2022, a 45% decrease. This $119,928 decrease was the result of a $77,958 decrease in revenues and a $41,970 increase in expenses.

Other Income (Expense)

On June 9, 2023, we reinvested $7,642,981 into U.S. Treasury bills that will mature on December 7, 2023. During the third quarter ended in 2023, we had noncash interest income of $102,017 from our investment in U.S. Treasury bills, whereas we had no interest income during the same period of 2022. We anticipate continued other income from the interest earned on our current investment in U.S. Treasury bills.

Income Tax Provision

We realized a $69,901, or 7%, decrease in our income tax provision during the three-month period ended September 30, 2023, compared to the same period in the prior year. The decrease in income tax provision was attributable to a 5% decrease in revenues, which was partially offset by a 4% increase in total expenses and a 100% increase in interest income.

Net Income

During the three-month period ended September 30, 2023, we realized a 5% decrease in total revenues, a 4% increase in total expenses, a 100% increase in noncash interest income, and a 7% decrease in our provision for income tax when compared to the same period in the prior year. The increase in noncash interest income of $102,017 was the result of interest earned on our U.S. Treasury bill investments during the three-month period ended September 30, 2023, whereas we had no interest income during the same period of 2022. The increase in interest income did not entirely offset the decrease in income from operations, and we realized a decrease of $12,884, or 7%, in net income during the three-month period ended September 30, 2023, compared to the three-month period ended September 30, 2022. We expect to have continued lower revenues for the remaining quarter of 2023 when compared to the same period in 2022, due to the continued effects of our loss of customers, but that interest income from our investments will continue to partially offset any decreases in revenue. We anticipate that this trend will continue to materially impact our net income during the balance of fiscal 2023 and potentially into 2024, although we anticipate that the losses will be partially offset by the expansion of our employee advocate program and interest earned on our investments.

Comparison of nine months ended September 30, 2023 and 2022

The following represents selected components of our consolidated results of operations for the nine-month periods ended September 201730, 2023 and 2016, respectively.  The increase of $116,313 was primarily the result of increases in outsource services required for utilization review, Medicare set aside fees and field case management fees.  We anticipate our outsource service fees will continue to move in correspondence2022, respectively, together with the level of utilization review, medical bill review and certain nurse case management services we provide in the future.  changes from period-to-period:

  

For nine months ended

September 30,

         
  

2023

  

2022

  

Amount Change

  

% Change

 

Revenues:

                

HCO

 $945,759  $985,192  $(39,433

)

  (4

%)

MPN

  392,789   422,227   (29,438

)

  (7

%)

Medical bill review

  266,030   333,310   (67,280

)

  (20

%)

Medical case management

  922,273   1,218,077   (295,804

)

  (24

%)

Utilization review

  1,360,998   1,220,941   140,057   11

%

Other

  99,727   102,084   (2,357

)

  (2

%)

Total revenues

  3,987,576   4,281,831   (294,255

)

  (7

%)

                 

Expenses:

                

Depreciation

  27,652   23,153   4,499   19

%

Bad debt provision

  2,429   (737

)

  3,166   430

%

Consulting fees

  173,235   166,309   6,926   4

%

Salaries and wages

  1,927,044   2,018,638   (91,594

)

  (5

%)

Professional fees

  263,880   222,703   41,177   18

%

Insurance

  229,599   238,851   (9,252

)

  (4

%)

Outsource service fees

  529,861   433,275   96,586   22

%

Data maintenance

  69,278   59,400   9,878   17

%

General and administrative

  390,019   418,079   (28,060

)

  (7

%)

Total expenses

  3,612,997   3,579,671   33,326   1

%

                 

Income from operations

  374,579   702,160   (327,581

)

  (47

%)

                 

Other income (expense)

                

Interest Income

  301,991   -   301,991   100

%

Total other income (expense)

  301,991   -   301,991   100

%

                 

Income before taxes

  676,570   702,160   (25,590

)

  (4

%)

Income tax provision

  (189,913

)

  (197,096

)

  7,183   (4

%)

                 

Net income

 $486,657  $505,064  $(18,407

)

  (4

%)



Data Maintenance

HCO


During the nine-month period ended September 30, 20172023, HCO revenue decreased 4% compared to the same period in the prior year. Due to the nature of their industries, our HCO customers had an increased frequency of COVID-19 claims during 2022, and 2016,as a result related revenue remained higher through the end of the third quarter of 2022. The decrease in HCO revenue was primarily due to a reduction in HCO claim network fees from fewer COVID-19 claims, which was partially offset by increases in HCO enrollment and notification fees related to an increase in the number of enrolled employees, when compared to the same period in the prior year.

MPN

During the nine-month period ended September 30, 2023, MPN revenue decreased 7% compared to the same period in the prior year. The decrease in MPN revenue was primarily attributable to the decrease in COVID-19 claims which generate MPN claim network fees. The decrease was partially offset by increases in the number of enrollees into our monthly MPN program.

Medical bill review

During the nine-month period ended September 30, 2023, medical bill review revenue decreased 20% compared to the same period in the prior year. The decrease was primarily due to fewer hospital and non-hospital bills reviewed for customers and the loss of two customers in the second quarter of 2023. The decrease was partially offset by the addition of a new customer in the fourth quarter of 2022.

Medical case management

During the nine-month period ended September 30, 2023, medical case management revenue decreased 24% compared to the same period in the prior year. The decrease was attributable to a decline in COVID-19 and non-COVID-19 claims from existing customers. During the pandemic, some of our customers opted to have COVID-19 claims assigned to a medical case manager, regardless of severity of the illness, and the trend continued into the third quarter of 2022. Since the third quarter of 2022, due largely to the severity and frequency of COVID-19 claims declining, our customers have stopped requiring a medical case manager to be assigned to those claims, which has adversely impacted medical case management revenues. The decrease in medical case management revenue was partially offset by increases in revenue generated from our employee advocate services.

Utilization review

During the nine-month period ended September 30, 2023, utilization review revenue increased 11% compared to the same period in the prior year. The increase in revenue was due to increases in utilization review referrals from existing customers and the addition of a new customer in the fourth quarter of 2022, partially offset by a decrease in utilization review referrals stemming from the loss of a customer in the second quarter of 2023.

Other

Other revenue for the nine-month period ended September 30, 2023, decreased 2% compared to the same period in the prior year. The decrease was mainly attributable to decreases in the number of referrals for Medicare set-aside. The decrease was partially offset by an increase in network access fee revenue from increased access to our network by preferred provider organizations.

Expenses

Total expenses for the nine-month period ended September 30, 2023, increased 1%, compared to the same period in the prior year. The increase was primarily attributable to increases in outsource service fees, professional fees, data maintenance, consulting fees, depreciation, and bad debt provision, which were $71,261partially offset by decreases in salaries & wages, general and $113,175, respectively.administrative, and insurance.

Depreciation

During the nine-month period ended September 30, 2023, depreciation expenses increased 19% compared to the same period in the prior year. The increase was primarily due to depreciating fixed assets that were purchased in the last twelve months.

Bad debt provision

During the nine-month period ended September 30, 2023, bad debt provision expenses increased 430% compared to the same period in the prior year stemming from invoice delays related to our utilization review and medical case management software transition, which impacted our ability to collect payments, and an abrupt closure of one of our customers in the second quarter of 2023. 

Salaries and wages

During the nine-month period ended September 30, 2023, salaries and wages decreased 5% compared to the same period in the prior year. The decrease of $41,914was due to us having fewer employees and was partially offset by an increase in wages and salaries for our existing employees.

Professional fees

During the nine-month period ended September 30, 2023, professional fees increased 18% compared to the same period in the prior year. The increase in professional fees was primarily the result of recording notificationadditional legal, field medical case management and accounting services, partially offset by decreases in other professional services. The increase in legal services was related to legal fees associatedstemming from a bill dispute and the data security incident during 2023, and the increase in accounting services was related to an employee retention credit, which is a refundable tax credit for businesses and tax-exempt organizations that had employees and were affected during the COVID-19 pandemic.

Outsource service fees

During the nine-month period ended September 30, 2023, outsource service fees increased 22% compared to the same period in the prior year. The increase in outsource service fees was primarily attributable to increased demand for our utilization review, HCO, field medical case management, and Medicare set-aside services, the provision of which utilize outsourced services. The increase was partially offset by decreases in the outsourced services for medical bill review due to fewer medical bills reviewed. Our outsourcing and related fees will continue to correspond with the additionlevel of a majormedical bill review, enrollees in our HCO, customerutilization review, certain field medical case management and Medicare set-aside services.

Data maintenance

During the nine-month period ended September 30, 2023, data maintenance fees increased 17% compared to the same period in the first quarter 2016, with a lower level of notificationprior year. The increase in data maintenance fees recordedwas due to increases in our customers’ employee counts for this same customerenrollment in our HCO and MPN programs, which have corresponding data maintenance needs.

General and administrative

General and administrative expenses decreased by 7% during the nine-month period ended September 30, 2017.


General2023 compared to the same period in the prior year. The decrease was primarily due to decreases in office rent, licenses and Administrativepermits, telephone, and a one-time credit for IT enhancement as a result of resolving a bill dispute. The decrease was partially offset by increases in dues and subscriptions, vacation expenses, advertising and marketing, auto expenses, and other general and administrative expenses.

Income from Operations

During the nine-month period ended September 30, 2017, general2023, income from operations was $374,579, compared to $702,160 during the same period in 2022, a 47% decrease. This $327,581 decrease was the result of a $294,255 decrease in revenues and administrative expenses increased 4% to $495,474 when compared to$33,326 increase in expenses.

Other Income (Expense)

During the nine-month period ended September 30, 2016.  This increase2023, we had interest income of $20,244$301,991 from our investment in U.S. Treasury bills which matured on June 8, 2023 and interest income on U.S. Treasury bills that will mature on December 7, 2023.  The total interest earned in U.S. Treasury bills that matured on June 8, 2023 was primarily attributable to increases in dues$202,693 and subscriptions, employment agency fees, IT enhancement, license and permits, telephone expense, rent expense, travel and entertainment expense and miscellaneous expense, partially offset by decreases in charitable contributions, auto expense, postage expense, office supplies and paid time off expense. We do not expect current levels of general and administrative expenses to materially increasewas recognized during the remaining monthssecond quarter of 2017.2023. On June 9, 2023, we reinvested $7,642,981 in U.S. Treasury bills with a maturity date of December 7, 2023. The noncash interest on the U.S. Treasury bills purchased on June 9, 2023 was $126,422. We anticipate continued net income from the interest earned on our current investment in U.S. Treasury bills.


Income from OperationsTax Provision


As

We realized a resultdecrease in our income tax provision of the 20% increase in total revenue$7,183, or 4%, during the nine-month period ended September 30, 2017, which was partially offset by the 6% increase in total expenses, our income from operations before taxes increased to $1,210,984, a 102% increase2023, compared to the same period in 2016. 


Income Tax Provision

Because we realizedthe prior year. The decrease in income before taxes of $1,210,984 and $598,970 during the nine-month periods ended September 30, 2017 and 2016, respectively, we realizedtax provision was attributable to a $254,789 or 102%,7% decrease in total revenues, which was partially offset by a 1% increase in our income tax provision. total expenses and 100% increase in interest income.


Net Income


During the nine-month period ended September 30, 2017,2023, we realized a 7% decrease in total revenues, of $4,817,800 was 20% highera 1% increase in total expenses, a 100% increase in interest income and a 4% decrease in our provision for income tax when compared to the same period in 2016.  This increasethe prior year. Decreases in total revenues was partiallywere offset by a 6% increase in total expenses, resulting in a 102% increase in income from operations.  Correspondingly, we realized netcash and noncash interest income of $706,666 for$301,991 from the interest earned on our U.S. Treasury bill investments during the nine-month period ended September 30, 2017, also2023. The increase in interest income did not entirely offset the decrease in income from operations, and we realized net income of $486,657, a 102% increase compared to4% decrease in net income during the nine-month period ended September 30, 2016. 2023, compared to the same period in the prior year. We expect to have continued lower revenues for the remaining quarter of 2023 when compared to the same period in 2022 as a result of fewer COVID-19 claims and the loss of two customers, but that interest income from our investments will continue to partially offset any decreases in revenue. We expect that the loss of customers will materially impact our net income during the balance of fiscal 2023 and potentially into 2024, although we anticipate the losses will be partially offset by the expansion of our employee advocate services and interest earned on our investments.


Liquidity and Capital Resources


Liquidity is a measurement of our ability to meet our potential cash requirements for general business purposes. We consistently monitor our liquidity and financial position and take actions management believes are in the best interest of the Company and its shareholders to ensure the long-term financial viability of the Company. Historically, we have realized positive cash flows from operating activities, which, coupled with positive reserves of cash on hand, have been used to fund our operating expenses and obligations.

We have focused on reducing other operating expenses while maintaining our ability to provide the high-quality services to which our customers are accustomed. For example, in April 2022 our office lease in Newport Beach, California expired, and we entered into a 12-month lease for a smaller office space in Irvine, California. In December 2022, we renewed the new office space lease for an additional 12-month period which will expire March 31, 2024. As a result of relocating to a smaller office and continuing to have our employees work remotely, we have decreased the operating costs for office expenses, but have utilized some of those savings to enhance our IT security, as well as other IT enhancements.

We currently have planned certain capital expenditures to replace our laptops and ancillary devices due to their age and as part of our ongoing continuity plan. We anticipate investing activities will continue throughout 2023 as we replace aging software, computer equipment, and further enhance our IT security. We anticipate these costs will be significant, but believe we have adequate capital on hand to cover these expenses. We do not anticipate these expenditures will require us to seek outside sources of funding.

During the nine-month period ended September 30, 2023, we realized net income of $486,657, as a result of interest income from our investment in U.S. Treasury bills and income from operations during that period. As of September 30, 2017,2023, we had $2,359,882 in cash on hand of $5,613,412 compared to $5,005,617$2,036,432 at December 31, 2016.2022. The $607,795$323,450 increase in cash on hand was primarilylargely due to decreases in accounts receivable from customers paying invoices that were outstanding due to problems in transitioning our operational software and decreases in accounts payable related to the resultresolution of net cash provided by our operating activities, partially offset by cash used in investing activities. Net cash provided by our operating activities wasa bill dispute with a vendor. Management currently believes that absent (i) the resultloss of realizing net income witha major customer, (ii) additional software issues, (iii) increases in accumulated depreciation, accrued expenses, and deferred rent expense, partially offset by decreases in our bad debt, prepaid expense, accounts payable, income tax payable, unearned revenues and increases in our accounts receivable. We used $13,446 in investing activities for purchases of computers, furniture and equipment.  Barring a significantor sustained inflation, (iv) an increased or longer-term downturn in the general economy, or the loss of major customers, we believe that(v) any unanticipated further adverse impacts related to COVID-19, cash on hand and anticipated revenues from operations will be sufficient to cover our operating expenses overfor at least the next twelve months.



We currently have planned certain capital expenditures during fiscal 2017 to support potential new customers’ software requirements. We do not expect these software expenditures to be material.   We do not anticipate this will require us to seek outside sources of funding. We do, however, from time to time, investigate potential opportunities to expand our business either through the creation of new business lines or the acquisition of existing businesses.  We are taking steps to look at acquisition candidates to vertically grow our Company.  In October 2017, we announced that we had retained a west-coast based investment banking firm to assist us in identifying potential merger and acquisition opportunities, as well as, to explore sources of institutional source of financing.   We have not found any suitable candidate at the current time.  We could use cash or stock of our Company or some combination of both in any expansion or acquisition.  An expansion or acquisition may require greater capital resources than we possess.  Should we need additional capital resources, we most likely would seek to obtain such through equity and/or debt financing.  There is no assurance that we could be successful in obtaining equity or debt financing on favorable terms, or at all.

Cash Flow


During

For the nine monthsnine-month period ended September 30, 2017,2023, cash was primarily used for the issuance of the one-time cash dividend in June 2023 and to fund operations. During the nine-month period ended September 30, 2023, cash used in financing activities consisted of a one-time cash dividend paid in June 2023. We had a net increase in cash of $607,795$323,450 and $554,691, during the nine monthsnine-month periods ended September 30, 2017.2023 and 2022, respectively. See below for additional information.discussion and analysis of cash flow.


For the nine months ended September  

For the nine months ended September 30,

 
2017
(unaudited)
 
2016
(unaudited)
  

2023

(unaudited)

  

2022

(unaudited)

 
            
Net cash provided from operating activities $621,241  $1,049,690 
Net cash used in investing activities  (13,446)  (33,556)

Net cash provided by operating activities

 $431,389  $572,310 

Net cash provided by (used in) investing activities

  1,101,328   (17,619

)

Net cash used in financing activities  -   (2,063)  (1,209,267

)

  - 
                
Net increase in cash $607,795  $1,014,071  $323,450  $554,691 

During the nine monthsnine-month period ended September 30, 2017 and 2016,2023, net cash provided by operating activities was $621,241$431,389, and $1,049,690, respectively.  As discussed herein, we realized$572,310 in the same period of 2022. The decrease in cash flow from operations during the first three quarters of 2023 was the result of realizing lower net income coupled with increases in income tax payable, accounts payable, prepaid income tax, prepaid expenses, unearned revenue, and other assets, partially offset by decreases in accounts receivable, accrued expenses, receivable – other, taxes receivable, and deferred rent assets. A large portion of $706,666the decrease in accounts receivable was due to customers paying the invoices that were outstanding due to problems in transitioning our operational software for utilization review and medical case management.

Net cash provided by investing activities was $1,101,328 during the nine monthsnine-month period ended September 30, 2017, compared to net income of $349,441 during the nine months ended September 30, 2016.  


Net cash2023, and $17,619 used in investing activities was $13,446 and $33,556 during the nine-month periodsperiod ended September 30, 2017 and 2016, respectively.  During2022. The increase in net cash provided by investing activities was due to the U.S. Treasury bills maturing, partially offset by the investment in new U.S. Treasury bills. We recognized interest of $202,693 for interest earned on our investments during the nine-month periodsperiod ended September 30, 2017 and 2016,2023. We expect net cash used in investing activities was used to purchaseincrease through 2023 and 2024 as we plan to update our current computer equipment, furniture and office equipment.


Net

During the nine-month period ended September 30, 2023, net cash used in financing activities was $1,209,267, which was the net amount of the one-time cash dividend paid in June 2023 of $1,281,600 and $72,333 in dividends payable. We did not engage in any financing activities during the nine-month periodsperiod ended September 30, 20172022.

Off-Balance Sheet Financing Arrangements

As of September 30, 2023, we had no off-balance sheet financing arrangements.

Inflation

We experience pricing pressures in the form of competitive pricing. Insurance carriers and 2016 was $0third-party administrators compete against us for customers by offering bundled claims administration services with their own managed care services at a lower rate. We are also impacted by rising costs for certain inflation-sensitive operating expenses such as labor and $2,063, respectively, resultingemployee benefits and facility leases. We believe that these impacts can be material to our revenues or net income. Some of our customers are public entities which contract with us at a fixed price for the term of the contract. Increases in labor and employee benefits can reduce our profit margin over the term of these contracts. See also “the effects of inflation may have a disproportionate impact on our business” of Item 1A Risk Factor of our Annual Report.

Critical Accounting Estimates

Our consolidated financial statements are prepared in accordance with accounting principles generally accepted in the United States (“GAAP”). Application of these principles requires us to make estimates, assumptions, and judgments that affect the amounts reported in our consolidated financial statements and accompanying notes. Because of the inherent uncertainty in making estimates and judgments, actual results could differ from lower cash dividends paid.our estimates and judgments. Our critical accounting policies are disclosed in Note 2, Significant Accounting Policies, of the Notes to Consolidated Financial Statements in our Annual Report and Note 1 and Note 2 to the Notes to the Condensed Consolidated Financial Statements in this quarterly report.


Summary

We continually evaluate our accounting estimates and judgments and base our estimates and judgments on historical experience and various other factors that we believe to be reasonable under the circumstances. Our critical accounting estimates include leases, allowance for uncollectible accounts, and income taxes, and are discussed in more detail below. Such accounting estimates require the most subjective or complex judgments by us, often as a result of Material Contractual Commitmentsthe need to make assumptions regarding matters that are inherently uncertain, and actual results could differ materially from these estimates.


Leases: We determine if an arrangement includes a lease at inception. Right-of-use assets represent our right to use an underlying asset for the lease term; and lease liabilities represent our obligation to make lease payments arising from the lease. Right-of-use assets and lease liabilities are recognized at the commencement date of the lease, renewal date of the lease or significant remodeling of the lease space based on the present value of the remaining future minimum lease payments. Leases with a term greater than one year are recognized on the balance sheet as right-of-use assets and short-term and long-term lease liabilities, as applicable.

Operating lease liabilities and their corresponding right-of-use assets are initially recorded based on the present value of lease payments over the expected remaining lease term. The followinginterest rate implicit in lease contracts is typically not readily determinable. As a summaryresult, we utilize our incremental borrowing rate to discount lease payments, which reflects the fixed rate at which we could borrow on a collateralized basis the amount of the lease payments in the same currency, for a similar term, in a similar economic environment. Our leases may include options to extend or terminate the lease which are included in the lease term when it is reasonably certain that we will exercise any such options. Lease expense for lease payments is recognized on a straight-line basis over the lease term.

Allowance for Uncollectible Accounts: We determine our allowance for uncollectible accounts by considering several factors, including the length of time trade accounts receivable are past due, our previous loss history, the customers’ current ability to pay its obligation to us, and the condition of the general economy and the industry as a whole. We write off accounts receivable when they become uncollectible.

We must make significant judgments and estimates in determining contractual and bad debt allowances in any accounting period. One significant uncertainty inherent in our analysis is whether our past experience will be indicative of future periods. Although we consider future projections when estimating contractual and bad debt allowances, we ultimately make our decisions based on the best information available to us at the time the decision is made. Adverse changes in general economic conditions or trends in reimbursement amounts for our services could affect our contractual and bad debt allowance estimates, collection of accounts receivable, cash flows, and results of operations. At September 30, 2023, three customers accounted for 10% or more of accounts receivable compared to three customers at December 31, 2022.

Accounting for Income Taxes: We record a tax provision for the anticipated tax consequences of our reported results of operations. The provision for income taxes is computed using the asset and liability method, under which deferred tax assets and liabilities are recognized for the expected future tax consequences of temporary differences between the financial reporting and tax bases of assets and liabilities, and for operating losses and tax credit carryforwards. Deferred tax assets and liabilities are measured using the currently enacted tax rates that apply to taxable income in effect for the years in which those tax assets are expected to be realized or settled. We record a valuation allowance, if necessary, to reduce deferred tax assets to the amount that is believed more likely than not to be realized.

We recognize tax benefits from uncertain tax positions only if it is more likely than not that the tax position will be sustained on examination by the taxing authorities, based on the technical merits of the position. The tax benefits recognized in the financial statements from such positions are then measured based on the largest benefit that has a greater than 50% likelihood of being realized upon ultimate settlement.

Management believes it is more likely than not that forecasted income, including income that may be generated as a result of certain tax planning strategies, together with future reversals of existing taxable temporary differences, will be sufficient to fully recover the deferred tax assets. In the event we determine all, or part of the net deferred tax assets are not realizable in the future, we will make an adjustment to the valuation allowance that would be charged to earnings in the period such determination is made. In addition, the calculation of tax liabilities involves significant judgment in estimating the impact of uncertainties in the application of GAAP and complex tax laws. Resolution of these uncertainties in a manner inconsistent with management’s expectations could have a material contractual commitments asimpact on our financial condition and operating results. The significant assumptions and estimates described above are important contributors to our ultimate effective tax rate each year.


 Payments Due By Period 
 Total Less than 1 year 1-3 years 3-5 years More than 5 years 
Operating Leases:          
Operating Leases – Equipment $56,857  $20,675  $36,182  $-  $- 
Office Leases $1,177,515   255,608   775,791   146,116   - 
Total Operating Leases $1,234,372  $276,283  $811,973  $146,116  $- 

Item 3. Quantitative and Qualitative DisclosureDisclosures about Market Risk


This information is

Smaller reporting companies are not required for smaller reporting companies.to provide this information.


Item 4. Controls and Procedures


Evaluation of Disclosure Controls and Procedures


We maintain “disclosure controls and procedures,” as defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act, which are controls and other procedures that are designed to provide reasonable assurance that information required to be disclosed by a company in the reports that it files or submits under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the Securities and Exchange Commission’sSEC’s rules and forms. Disclosure controls and procedures include, without limitation, controls and procedures designed to ensure that information required to be disclosed by a company in the reports that it files or submits under the Exchange Act is accumulated and communicated to the company’s management, including its principal executive and principal financial officers, as appropriate to allow timely decisions regarding required disclosure.


Our management, under the supervision and with the participation of our principal executive officer and principal financial officer, conducted an evaluation of the effectiveness of our disclosure controls and procedures as of the end of the period covered by this quarterly report on Form 10-Q.report. Based on the evaluation of our disclosure controls and procedures as of September 30, 2017,2023, the end of the period covered by this quarterly report, our Chief Executive Officer and Chief Financial Officer concluded that our disclosure controls and procedures were effective at a reasonable assurance level.


Changes in Internal Control over Financial Reporting


There were no changes in our internal control over financial reporting (as defined in Rules 13a-15(f) and 15d-15(f) under the Exchange Act) during the quarter ended September 30, 2017,2023, that materially affected or are reasonably likely to materially affect, our internal control over financial reporting.



PART II. OTHER INFORMATION


Item 1A. Risk Factors


Management does not believe there have been any material changes to the risk factors listed in Part I, “ItemItem 1A, Risk Factors”Factors in our annual report on Form 10-K for the year ended December 31, 2016.  These risk factors should be carefully considered with the information provided elsewhere in this report, which could materially adversely affect our business, financial condition or results of operations.Annual Report.

Item 6. Exhibits

Exhibits. The following exhibits are filed or furnished, as applicable, as part of this quarterly report:

Exhibit Number

 

Title of Document

   

Exhibit 31.1

 

   

Exhibit 31.2

 

   

Exhibit 32.1

 

   

Exhibit 101

 The

Pursuant to Rules 405 and 406 of Regulation S-T, the following materials from Pacific Health Care Organization, Inc.’s Quarterly Report on Form 10-Q for the period ended September 30, 2017,information is formatted in XBRL (eXtensibleiXBRL (Inline eXtensible Business Reporting Language): (i) the Unaudited Condensed Consolidated Balance Sheets as of September 30, 2023 and December 31, 2022, (ii) the Unaudited Condensed Consolidated Statements of Operations for the Three and Nine Months Ended September 30, 2023 and 2022, (iii) the Unaudited Condensed Consolidated Statements of Stockholder’s Equity for the Three and Nine Months Ended September 30, 2023 and 2022, (iv) the Unaudited Condensed Consolidated Statements of Cash Flows for the Nine Months Ended September 30, 2023 and (iv)2022, (v) Notes to the Unaudited Condensed Consolidated Financial Statements.Statements, and (vi) the cover page.

Exhibit 104

Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101)



SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this quarterly report to be signed on its behalf by the undersigned, thereunto duly authorized.

  

PACIFIC HEALTH CARE ORGANIZATION, INC.

    
    

Date:

November 14, 20172023

/s/ Tom Kubota

 
  

Tom Kubota

Chief Executive Officer


    

Date:

November 14, 20172023

/s/ Fred OdakaKristina Kubota

 
  
Fred Odaka

Kristina Kubota

Chief Financial Officer

21
26
iso4217:USD xbrli:shares